Ocugen, Inc. (OCGN)
1.595
+0.06
(+3.57%)
USD |
NASDAQ |
Jan 07, 16:00
1.595
0.00 (0.00%)
After-Hours: 18:01
Ocugen Research and Development Expense (Annual): 30.16M for Dec. 31, 2024
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Pfizer Inc. | 10.74B |
| CorMedix, Inc. | 3.942M |
| Belite Bio, Inc. | 29.94M |
| MannKind Corp. | 45.89M |
| Vertex Pharmaceuticals, Inc. | 3.630B |